Biomizone

Pharmaceutical form A satisfactory solution
Route of administration Deep intramuscular, subcutaneous
Pharmaceutical Classification Antibiotics
Target species:
Type: Pets, Farm animals
Description:
Broad-spectrum antibiotic plus non-steroidal anti-inflammatory drug

BIOMIZONA is indicated for the treatment and control of systemic and local diseases with inflammatory processes caused by Gram-positive, Gram-negative, aerobic, and anaerobic microorganisms, including rickettsiae, protozoa, and mycoplasmas susceptible to oxytetracycline, which cause respiratory, digestive, urinary, and genital infections, as well as septicemia. Specific conditions include: keratoconjunctivitis, chlamydiosis, anaplasmosis, symptomatic anthrax, malignant edema, listeriosis, actinomycosis, actinobacillosis, nocardiosis, mycoplasmosis, and hemobartonellosis. It is also indicated for foot ulcers, pyoderma, abscesses, infectious polyarthritis, erysipelas, leptospirosis, atrophic rhinitis, chronic respiratory disease, infectious coryza, cholera, spirochetosis, infectious sinusitis, and pullorum disease.

Bottles of 20 mL, 50 mL, 100 mL, 250 mL and 500 mL.

Each 1 mL contains:

Oxytetracycline HCl ………………………… 50 mg
Benzydamine HCl………………………….. 20 mg
Excipients csp ………………………….. 1 mL

Deep intramuscular or subcutaneous injection, except in birds, where it is only administered
The subcutaneous route is recommended.

? Cattle, sheep, goats, South American camelids, horses and pigs: 1 mL/10 kg of body weight
Canines and felines: 1mL/5 kg of body weight
? Poultry: 0.5 mL/kg of body weight
In cases of Anaplasmosis: 6 mL/25 kg of body weight
*Administer every 24 hours for 3 to 5 days, according to the evolution of the disease and the recovery of the animal, under the indication of the Veterinarian.